Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.

3.05
EUR
-0.21
(-6.43%)
-0.52EPS
703.45MMarket Cap
Feb 25Next Earn

Aclaris Therapeutics, Inc. Documents

Q3 FY2024 · Press release

2 pages

Read Aclaris Therapeutics, Inc.'s results firsthand

Preview this press release
Create a free account to start reading

Full documents are included with Professional

Q3 FY2024 documents